CS logo
small CS logo
AU-Melbourne-RMELBOURNE

Melbourne, Australia
City in Victoria

About AU-Melbourne-RMELBOURNE


Melbourne is the coastal capital of the southeastern Australian state of Victoria. At the city's centre is the modern Federation Square development, with plazas, bars, and restaurants by the Yarra River. In the Southbank area, the Melbourne Arts Precinct is the site of Arts Centre Melbourne – a performing arts complex – and the National Gallery of Victoria, with Australian and indigenous art. ― Google
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at AU-Melbourne-RMELBOURNE


During the past decade, AU-Melbourne-RMELBOURNE conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "AU-Melbourne-RMELBOURNE" #1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator and "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at AU-Melbourne-RMELBOURNE


According to Clinical.Site data, the most researched conditions in "AU-Melbourne-RMELBOURNE" are "Acute Myeloid Leukemia" (2 trials) and "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials). Many other conditions were trialed in "AU-Melbourne-RMELBOURNE" in a lesser frequency.

Clinical Trials Intervention Types at AU-Melbourne-RMELBOURNE


Most popular intervention types in "AU-Melbourne-RMELBOURNE" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "AG-120" (1 trials), "AG-221" (1 trials), "Gilteritinib" (1 trials), "Midostaurin" (1 trials) and "Placebo for AG-120" (1 trials). Other intervention names were less common.

Clinical Trials Genders at AU-Melbourne-RMELBOURNE


The vast majority of trials in "AU-Melbourne-RMELBOURNE" are 2 trials for "All" genders.

Clinical Trials Status at AU-Melbourne-RMELBOURNE


Currently, there are NaN active trials in "AU-Melbourne-RMELBOURNE". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in AU-Melbourne-RMELBOURNE, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in AU-Melbourne-RMELBOURNE, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".